AXL and neoplasm: These findings highlight AXL’s dual role in mediating both tumor-intrinsic aggressiveness and tumor-extrinsic immune suppression and support AXL inhibition as a strategy to overcome two major mechanisms of therapeutic resistance in TNBC.